Company Profile
- Stock Code
- BIIB
- ISIN Code
- US09062X1037
- Currency
- US Dollar (USD)
- IPO Date
- 1991-09-16

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral scle...